These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2584710

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC, Sairenji T, Humphreys RE.
    J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Invariant chain influences post-translational processing of HLA-DR molecules.
    Schaiff WT, Hruska KA, Bono C, Shuman S, Schwartz BD.
    J Immunol; 1991 Jul 15; 147(2):603-8. PubMed ID: 2071896
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biosynthesis and processing of class II histocompatibility antigens.
    Cresswell P, Blum JS, Kelner DN, Marks MS.
    Crit Rev Immunol; 1987 Jul 15; 7(1):31-53. PubMed ID: 3545672
    [Abstract] [Full Text] [Related]

  • 11. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C, Schwenk F, Koch N, Möller P.
    Immunology; 1995 Feb 15; 84(2):177-82. PubMed ID: 7750992
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
    Germain RN, Rinker AG.
    Nature; 1993 Jun 24; 363(6431):725-8. PubMed ID: 8515815
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fatty acylation of murine Ia alpha, beta, and invariant chains.
    Simonis S, Cullen SE.
    J Immunol; 1986 Apr 15; 136(8):2962-7. PubMed ID: 3082975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH, Lien LL, Benacerraf B, Rock KL.
    J Immunol; 1993 May 15; 150(10):4206-17. PubMed ID: 8482833
    [Abstract] [Full Text] [Related]

  • 19. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV, Reyes VE, Humphreys RE.
    Arch Biochem Biophys; 1995 Feb 20; 317(1):128-32. PubMed ID: 7872774
    [Abstract] [Full Text] [Related]

  • 20. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L, Kovats S, Eastman S, Rudensky AY.
    J Immunol; 1996 Mar 15; 156(6):2196 - 2204. PubMed ID: 8690909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.